Cost-effectiveness of exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: protocol for an economic evaluation alongside the SITLESS three-armed pragmatic randomised controlled trial

Manuela Deidda, Laura Coll-Planas, Maria Giné-Garriga, Míriam Guerra-Balic, Marta Roqué I Figuls, Mark A Tully, Paolo Caserotti, Dietrich Rothenbacher, Antoni Salvà Casanovas, Frank Kee, Nicole E Blackburn, Jason J Wilson, Mathias Skjødt, Michael Denkinger, Katharina Wirth, Emma McIntosh, SITLESS Team, Manuela Deidda, Laura Coll-Planas, Maria Giné-Garriga, Míriam Guerra-Balic, Marta Roqué I Figuls, Mark A Tully, Paolo Caserotti, Dietrich Rothenbacher, Antoni Salvà Casanovas, Frank Kee, Nicole E Blackburn, Jason J Wilson, Mathias Skjødt, Michael Denkinger, Katharina Wirth, Emma McIntosh, SITLESS Team

Abstract

Introduction: Promoting physical activity (PA) and reducing sedentary behaviour (SB) may exert beneficial effects on the older adult population, improving behavioural, functional, health and psychosocial outcomes in addition to reducing health, social care and personal costs. This paper describes the planned economic evaluation of SITLESS, a multicountry three-armed pragmatic randomised controlled trial (RCT) which aims to assess the short-term and long-term effectiveness and cost-effectiveness of a complex intervention on SB and PA in community-dwelling older adults, based on exercise referral schemes enhanced by a group intervention providing self-management strategies to encourage lifestyle change.

Methods and analysis: A within-trial economic evaluation and long-term model from both a National Health Service/personal social services perspective and a broader societal perspective will be undertaken alongside the SITLESS multinational RCT. Healthcare costs (hospitalisations, accident and emergency visits, appointment with health professionals) and social care costs (eg, community care) will be included in the economic evaluation. For the cost-utility analysis, quality-adjusted life-years will be measured using the EQ-5D-5L and capability well-being measured using the ICEpop CAPability measure for Older people (ICECAP-O) questionnaire. Other effectiveness outcomes (health related, behavioural, functional) will be incorporated into a cost-effectiveness analysis and cost-consequence analysis.The multinational nature of this RCT implies a hierarchical structure of the data and unobserved heterogeneity between clusters that needs to be adequately modelled with appropriate statistical and econometric techniques. In addition, a long-term population health economic model will be developed and will synthesise and extrapolate within-trial data with additional data extracted from the literature linking PA and SB outcomes with longer term health states.Methods guidance for population health economic evaluation will be adopted including the use of a long-time horizon, 1.5% discount rate for costs and benefits, cost consequence analysis framework and a multisector perspective.

Ethics and dissemination: The study design was approved by the ethics and research committee of each intervention site: the Ethics and Research Committee of Ramon Llull University (reference number: 1314001P) (Fundació Blanquerna, Spain), the Regional Committees on Health Research Ethics for Southern Denmark (reference number: S-20150186) (University of Southern Denmark, Denmark), Office for Research Ethics Committees in Northern Ireland (ORECNI reference number: 16/NI/0185) (Queen's University of Belfast) and the Ethical Review Board of Ulm University (reference number: 354/15) (Ulm, Germany). Participation is voluntary and all participants will be asked to sign informed consent before the start of the study.This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement number 634 270. This article reflects only the authors' view and the Commission is not responsible for any use that may be made of the information it contains.The findings of the study will be disseminated to different target groups (academia, policymakers, end users) through different means following the national ethical guidelines and the dissemination regulation of the Horizon 2020 funding agency.Use of the EuroQol was registered with the EuroQol Group in 2016.Use of the ICECAP-O was registered with the University of Birmingham in March 2017.

Trial registration number: NCT02629666; Pre-results.

Keywords: complex interventions; economic evaluation; older adults; physical activity; sedentary behaviour; self-management strategies.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Owen N, Healy GN, Matthews CE, et al. . Too much sitting: the population health science of sedentary behavior. Exerc Sport Sci Rev 2010;38:105 10.1097/JES.0b013e3181e373a2
    1. Beale SJ, Bending MW, Trueman P, et al. . Should we invest in environmental interventions to encourage physical activity in England? An economic appraisal. Eur J Public Health 2012;22:869–73. 10.1093/eurpub/ckr151
    1. ISCA-CEBR. The economic cost of physical inactivity in Europe. 2015.
    1. WHO. Global Health and Ageing. Geneva, Switzerland: World Health Organisation, US National Institute of Aging, 2011.
    1. Economic Policy Committee. Budgetary challenges posed by ageing populations. 2001.
    1. Dishman R, Heath G, Lee I-M. Physical activity epidemiology: human kinetics. 2013.
    1. Buckinx F, Rolland Y, Reginster JY, et al. . Burden of frailty in the elderly population: perspectives for a public health challenge. Arch Public Health 2015;73:19 10.1186/s13690-015-0068-x
    1. Kujala UM. Evidence on the effects of exercise therapy in the treatment of chronic disease. Br J Sports Med 2009;43:550–5. 10.1136/bjsm.2009.059808
    1. Peterson MJ, Sloane R, Cohen HJ, et al. . Effect of telephone exercise counseling on frailty in older veterans: project LIFE. Am J Mens Health 2007;1:326–34. 10.1177/1557988307306153
    1. Kenny AM, Boxer RS, Kleppinger A, et al. . Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J Am Geriatr Soc 2010;58:1707–14. 10.1111/j.1532-5415.2010.03019.x
    1. WHO. Active ageing: a policy framework. 2002.
    1. Williams NH, Hendry M, France B, et al. . Effectiveness of exercise-referral schemes to promote physical activity in adults: systematic review. Br J Gen Pract 2007;57:979–86. 10.3399/096016407782604866
    1. Garrett S, Elley CR, Rose SB, et al. . Are physical activity interventions in primary care and the community cost-effective? A systematic review of the evidence. Br J Gen Pract 2011;61:e125–33. 10.3399/bjgp11X561249
    1. Pavey TG, Anokye N, Taylor AH, et al. . The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation. Health Technol Assess 2011;15:1–254. 10.3310/hta15440
    1. Cobiac LJ, Vos T, Barendregt JJ. Cost-effectiveness of interventions to promote physical activity: a modelling study. PLoS Med 2009;6:e1000110 10.1371/journal.pmed.1000110
    1. Pentecost C, Farrand P, Greaves CJ, et al. . Combining behavioural activation with physical activity promotion for adults with depression: findings of a parallel-group pilot randomised controlled trial (BAcPAc). Trials 2015;16:16 10.1186/s13063-015-0881-0
    1. Isaacs AJ, Critchley JA, Tai SS, et al. . Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only. Health Technol Assess 2007;11:1 10.3310/hta11100
    1. Murphy SM, Edwards RT, Williams N, et al. . An evaluation of the effectiveness and cost effectiveness of the National Exercise Referral Scheme in Wales, UK: a randomised controlled trial of a public health policy initiative. J Epidemiol Community Health 2012;66:745–53. 10.1136/jech-2011-200689
    1. Gusi N, Reyes MC, Gonzalez-Guerrero JL, et al. . Cost-utility of a walking programme for moderately depressed, obese, or overweight elderly women in primary care: a randomised controlled trial. BMC Public Health 2008;8:231 10.1186/1471-2458-8-231
    1. Munro J, Brazier J, Davey R, et al. . Physical activity for the over-65s: could it be a cost-effective exercise for the NHS? J Public Health Med 1997;19:397–402. 10.1093/oxfordjournals.pubmed.a024667
    1. Clare L, Hindle JV, Jones IR, et al. . The AgeWell study of behavior change to promote health and wellbeing in later life: study protocol for a randomized controlled trial. Trials 2012;13:115 10.1186/1745-6215-13-115
    1. Cochrane T, Davey RC, Matthes Edwards SM. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis. Health Technol Assess 2005;9:1–114. 10.3310/hta9310
    1. Hurley MV, Walsh NE, Mitchell HL, et al. . Economic evaluation of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain. Arthritis Rheum 2007;57:1220–9. 10.1002/art.23011
    1. de Vries NM, Staal JB, van der Wees PJ, et al. . Patient-centred physical therapy is (cost-) effective in increasing physical activity and reducing frailty in older adults with mobility problems: a randomized controlled trial with 6 months follow-up. J Cachexia Sarcopenia Muscle 2016;7:422–35. 10.1002/jcsm.12091
    1. Groessl EJ, Kaplan RM, Castro Sweet CM, et al. . Cost-effectiveness of the LIFE Physical activity intervention for older adults at increased risk for mobility disability. J Gerontol A Biol Sci Med Sci 2016;71:656–62. 10.1093/gerona/glw001
    1. Owen L, Morgan A, Fischer A, et al. . The cost-effectiveness of public health interventions. J Public Health 2012;34:37–45. 10.1093/pubmed/fdr075
    1. Anokye NK, Trueman P, Green C, et al. . Physical activity and health related quality of life. BMC Public Health 2012;12:624 10.1186/1471-2458-12-624
    1. Giné-Garriga M, Coll-Planas L, Guerra M, et al. . The SITLESS project: exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: study protocol for a randomised controlled trial. Trials 2017;18:221 10.1186/s13063-017-1956-x
    1. NICE. Physical activity: exercise referral schemes. 2014.
    1. van der Bij AK, Laurant MG, Wensing M. Effectiveness of physical activity interventions for older adults: a review. Am J Prev Med 2002;22:120–33. 10.1016/S0749-3797(01)00413-5
    1. Chiang KC, Seman L, Belza B, et al. . ‘It is our exercise family’: experiences of ethnic older adults in a group-based exercise program. Prev Chronic Dis 2008;5.
    1. Chang AK, Fritschi C, Kim MJ. Sedentary behavior, physical activity, and psychological health of Korean older adults with hypertension: effect of an empowerment intervention. Res Gerontol Nurs 2013;6:81–8. 10.3928/19404921-20121219-01
    1. Morgan O. Approaches to increase physical activity: reviewing the evidence for exercise-referral schemes. Public Health 2005;119:361–70. 10.1016/j.puhe.2004.06.008
    1. Campbell F, Holmes M, Everson-Hock E, et al. . A systematic review and economic evaluation of exercise referral schemes in primary care: a short report. Health Technol Assess 2015;19:1–110. 10.3310/hta19600
    1. Owen N, Sugiyama T, Eakin EE, et al. . Adults' sedentary behavior determinants and interventions. Am J Prev Med 2011;41:189–96. 10.1016/j.amepre.2011.05.013
    1. Bauman AE, Reis RS, Sallis JF, et al. . Correlates of physical activity: why are some people physically active and others not? Lancet 2012;380:258–71. 10.1016/S0140-6736(12)60735-1
    1. Nour K, Laforest S, Gauvin L, et al. . Behavior change following a self-management intervention for housebound older adults with arthritis: an experimental study. Int J Behav Nutr Phys Act 2006;3:12 10.1186/1479-5868-3-12
    1. Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ 2011;342:d1548 10.1136/bmj.d1548
    1. NICE. Methods for the development of NICE public health guidance. London: National Institute for Clinical Excellence, 2012.
    1. Husereau D, Drummond M, Petrou S, et al. . Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health 2013;16:231–50. 10.1016/j.jval.2013.02.002
    1. Sculpher MJ, Pang FS, Manca A, et al. . Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess 2004;8:1–192. 10.3310/hta8490
    1. Drummond M, Pang F. Transferability of economic evaluation results. Economic evaluation in healthcare: merging theory with practice,. 2001.
    1. Drummond MF, Sculpher MJ, Claxton K, et al. . Methods for the economic evaluation of health care programmes: Oxford university press, 2015.
    1. Euro-Qol-Group, 2015. The EQ-5D-5L User Guide 2015.
    1. University of Birmingham, 2016. ICECAP-O Secondary.
    1. Sen A. Choice, welfare and measurement: Harvard University Press, 1997.
    1. Makai P, Looman W, Adang E, et al. . Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter? Eur J Health Econ 2015;16:437–50. 10.1007/s10198-014-0583-7
    1. Sørensen JB, Skovgaard T, Puggaard L. Exercise on prescription in general practice: a systematic review. Scand J Prim Health Care 2006;24:69–74. 10.1080/02813430600700027
    1. Szende A, Oppe M, Devlin N. EQ-5D valuation sets: inventory, comparative review and user guide: Springer, 2007.
    1. Badia X, Roset M, Herdman M, et al. . A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 2001;21:7–16. 10.1177/0272989X0102100102
    1. Karlsson JA, Nilsson JÅ, Neovius M, et al. . National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients. Ann Rheum Dis 2011;70:2163–6. 10.1136/ard.2011.153437
    1. NICE, 2017. Position statement on use of the EQ-5D-5L valuation set. Secondary position statement on use of the EQ-5D-5L valuation set.
    1. van Hout B, Janssen MF, Feng YS, et al. . Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15. 10.1016/j.jval.2012.02.008
    1. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487–96. 10.1002/hec.944
    1. Rivero-Arias O, Gray A. The multinational nature of cost-effectiveness analyses alongside multinational clinical trials. Value Health 2010;13:34–41. 10.1111/j.1524-4733.2009.00582.x
    1. Vemer P, Rutten-van Mölken MP. The road not taken: transferability issues in multinational trials. Pharmacoeconomics 2013;31:863–76. 10.1007/s40273-013-0084-z
    1. Oppong R, Jowett S, Roberts TE. Economic evaluation alongside multinational studies: a systematic review of empirical studies. PLoS One 2015;10:e0131949 10.1371/journal.pone.0131949
    1. Ramsey SD, Willke RJ, Glick H, et al. . Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value Health 2015;18:161–72. 10.1016/j.jval.2015.02.001
    1. Glick HA, Doshi JA, Sonnad SS, et al. . Economic evaluation in clinical trials. OUP: Oxford, 2014.
    1. Harris T, Kerry SM, Victor CR, et al. . A primary care nurse-delivered walking intervention in older adults: PACE (pedometer accelerometer consultation evaluation)-Lift cluster randomised controlled trial. PLoS Med 2015;12:e1001783 10.1371/journal.pmed.1001783
    1. Pang F. Design, analysis and presentation of multinational economic studies: the need for guidance. Pharmacoeconomics 2002;20:75–90.
    1. Manca A, Sculpher MJ, Goeree R. The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. Pharmacoeconomics 2010;28:1079–96. 10.2165/11537760-000000000-00000
    1. Rice N, Jones A. Multilevel models and health economics. Health Econ 1997;6:561–75. 10.1002/(SICI)1099-1050(199711)6:6<561::AID-HEC288>;2-X
    1. Adalsteinsson E, Toumi M. Benefits of probabilistic sensitivity analysis - a review of NICE decisions. J Mark Access Health Policy 2013;1:21240 10.3402/jmahp.v1i0.21240
    1. Woods B, Revill P, Sculpher M, et al. . Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health 2016;19:929–35. 10.1016/j.jval.2016.02.017
    1. Ramsey S, Willke R, Briggs A, et al. . Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA task force report. Value Health 2005;8:521–33. 10.1111/j.1524-4733.2005.00045.x
    1. Oostenbrink JB, Al MJ, Mj A. The analysis of incomplete cost data due to dropout. Health Econ 2005;14:763–76. 10.1002/hec.966
    1. Faria R, Gomes M, Epstein D, et al. . A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics 2014;32:1157–70. 10.1007/s40273-014-0193-3
    1. Frew EJ, Bhatti M, Win K, et al. . Cost-effectiveness of a community-based physical activity programme for adults (Be Active) in the UK: an economic analysis within a natural experiment. Br J Sports Med 2014;48:207–12. 10.1136/bjsports-2012-091202
    1. Roux L, Pratt M, Tengs TO, et al. . Cost effectiveness of community-based physical activity interventions. Am J Prev Med 2008;35:578–88. 10.1016/j.amepre.2008.06.040
    1. Ekelund U, Steene-Johannessen J, Brown WJ, et al. . Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. The Lancet 2016;388:1302–10. 10.1016/S0140-6736(16)30370-1
    1. Glynn NW, Santanasto AJ, Simonsick EM, et al. . The pittsburgh fatigability scale for older adults: development and validation. J Am Geriatr Soc 2015;63:130–5. 10.1111/jgs.13191

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera